| PERIOD ENDING | 31-Jan-09 | 31-Jan-08 | 31-Jan-07 | | Total Revenue | 119,920 | 122,376 | 115,673 | | Cost of Revenue | 87,839 | 92,501 | 89,030 | | | Gross Profit | 32,081 | 29,875 | 26,643 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 24,655 | 24,071 | 22,176 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 7,426 | 5,804 | 4,467 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (15) | 414 | 111 | | Earnings Before Interest And Taxes | 7,455 | 6,360 | 4,779 | | Interest Expense | 2,053 | 1,950 | 1,801 | | Income Before Tax | 5,402 | 4,410 | 2,978 | | Income Tax Expense | 2,342 | 1,711 | 1,309 | | Minority Interest | (82) | (84) | (88) | | | | Net Income From Continuing Ops | 2,978 | 2,615 | 1,581 | | | Non-recurring Events | | Discontinued Operations | 662 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 3,640 | 2,615 | 1,581 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,640 | $2,615 | $1,581 |
|
0.22% Nasdaq 
Income Statement
